Gene · 10644
Papers3,666
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,666
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IGF2BP2 Promotes Esophageal Squamous-Cell Carcinoma Progression with Potential Involvement of PI3K/AKT Signaling. | Curr Issues Mol Biol | 2026 | 42510966 | PubTator, text mining | PubMed |
| The m6A reader IGF2BP2 promotes hepatic fibrosis by stabilizing AEBP1 mRNA and regulating GRB2-mediated hepatic stellate cell activation. | Biochim Biophys Acta Mol Basis Dis | 2026 | 42508775 | PubTator, text mining | PubMed |
| Deltacoronavirus Modulates circRNA cGLIS3 Metabolism to Evade Host Antiviral Response. | Adv Sci (Weinh) | 2026 | 42505069 | PubTator, text mining | PubMed |
| GATA6-mediated transcriptional activation and METTL3/IGF2BP2-dependent post-transcriptional stabilization upregulate CDC20 to promote the malignant progression of colorectal cancer and immune escape. | Hum Cell | 2026 | 42501233 | PubTator, text mining | PubMed |
| The m6A Reader IGF2BP2 Suppresses Ferroptosis in Nasopharyngeal Carcinoma by Stabilizing NRF2 mRNA. | Biochem Genet | 2026 | 42496933 | PubTator, text mining | PubMed |
| N6-methyladenosine-mediated upregulation of PAICS promotes lung-adenocarcinoma metastasis via the integrin-FAK signaling. | Oncogene | 2026 | 42493545 | PubTator, text mining | PubMed |
| 6-Gingerol alleviates hepatic fibrosis via inhibiting glycolytic reprogramming by targeting IGF2BP2. | Chin Herb Med | 2026 | 42488840 | PubTator, text mining | PubMed |
| Metabolic splicing subtypes elucidate metastatic trajectories and clinical biomarkers in adrenocortical carcinoma. | Comput Methods Programs Biomed | 2026 | 42485906 | PubTator, text mining | PubMed |
| Lactate-associated H3K18 lactylation is involved in IGF2BP2-mediated MARCKSL1 mRNA stabilization and inflammatory signaling in LPS-induced acute lung injury. | Mol Immunol | 2026 | 42468439 | PubTator, text mining | PubMed |
| m6A-modified lncRNA MIAT promotes anoikis resistance and peritoneal metastasis of colorectal cancer through miR-181a-5p/MCL1 signaling axis. | Int Immunopharmacol | 2026 | 42468168 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomic analysis reveal distinct tumor microenvironment signatures in primary and recurrent hypopharyngeal squamous cell carcinoma. | Cell Mol Biol Lett | 2026 | 42443752 | PubTator, text mining | PubMed |
| RHBDD2 Confers Insensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Ferroptosis Through the Wnt3a/β-Catenin/FTH1 Axis. | Cell Biochem Biophys | 2026 | 42440245 | PubTator, text mining | PubMed |
| PYRIN m6A modification drives cardiomyocyte PANoptosis in sepsis-induced cardiomyopathy. | Acta Pharmacol Sin | 2026 | 42410248 | PubTator, text mining | PubMed |
| Rare protein-coding variation and the genetic architecture of height in >1.4 million individuals. | medRxiv | 2026 | 42396316 | PubTator, text mining | PubMed |
| CD90 mediates gastric cancer immune evasion though regulating IGF2BP2 to stabilize the m6A-CD47/SIRPα axis. | Cancer Cell Int | 2026 | 42380953 | PubTator, text mining | PubMed |
| The TNRC6B/circTNRC6B axis drives lymphovascular invasion and metastasis through an intragenic self-degradation loop. | Cell Rep | 2026 | 42360875 | PubTator, text mining | PubMed |
| Machine Learning-Based Integration Unveils RNA Methylation Regulator-Related Immune-Derived Gene Signatures in Ruptured Intracranial Aneurysm. | Biomedicines | 2026 | 42351682 | PubTator, text mining | PubMed |
| Loganin triggers ferroptosis in renal cell carcinoma by targeting the IGF2BP2/HMOX1 axis in an m6A-dependent manner. | Biochem Pharmacol | 2026 | 42349616 | PubTator, text mining | PubMed |
| Translational regulation of Sf1 integrates alternative splicing and hematopoietic stem cell fate. | Blood | 2026 | 42345356 | PubTator, text mining | PubMed |
| piR-26681 suppresses ovarian cancer progression by enhancing METTL3/METTL14-mediated m6A modification of FBXO16 and impairing DNA repair via MORF4L1 degradation. | Cell Mol Biol Lett | 2026 | 42343215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10644/papers?page=2